about
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.Cardiobacterium hominis endocarditis: Two cases and a review of the literatureEmergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USACyclooxygenase inhibition in sepsis: is there life after death?Viral Infections of the Central Nervous System: A Case-Based ReviewAspirin and Reye's syndrome: discovery of aspirin and paracetamolThe acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient miceRap1 activation is required for Fc gamma receptor-dependent phagocytosisActivation of phosphatase and tensin homolog on chromosome 10 mediates the inhibition of FcgammaR phagocytosis by prostaglandin E2 in alveolar macrophagesFcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functionsLeukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidaseNo Impairment in host defense against Streptococcus pneumoniae in obese CPEfat/fat mice.Clinical and laboratory features of Streptococcus salivarius meningitis: a case report and literature review.Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosisMicrobiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.Fever and hypothermia in systemic inflammation: recent discoveries and revisions.Severe hemorrhage complicating the Klippel-Trénaunay-Weber syndrome.Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotypingE-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infectionBlunt trauma as a risk factor for group A streptococcal necrotizing fasciitisCigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis.Mandibular Actinomyces osteomyelitis complicating florid cemento-osseous dysplasia: case report.New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases.Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients.Epidemiology of Clostridium difficile infectionFecal microbiota therapy: ready for prime time?Comparative analysis of the extracellular proteomes of two Clostridium sordellii strains exhibiting contrasting virulenceThe role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study.Association and virulence gene expression vary among serotype III group B streptococcus isolates following exposure to decidual and lung epithelial cells.Procalcitonin levels associate with severity of Clostridium difficile infectionClostridium difficile-induced colitis in mice is independent of leukotrienesDistinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages.Depression, antidepressant medications, and risk of Clostridium difficile infectionTcsL is an essential virulence factor in Clostridium sordellii ATCC 9714Using live pathogens to treat infectious diseases: a historical perspective on the relationship between GB virus C and HIV.Pseudo-outbreak of Clostridium sordellii infection following probable cross-contamination in a hospital clinical microbiology laboratory.Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis.Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model.
P50
Q24531388-A23D648F-E968-41D6-8665-2D2B74A93E53Q24648255-D4D60F57-D91E-4D4E-8A3B-F34910F433B7Q27009117-A3659E47-0225-4F4A-9CD4-E3981DB133A5Q27024316-60F79BB6-E322-4404-936B-5DD504D9F62FQ27490778-8AD5B64C-8C8F-47C6-8C7F-DCB0C4318BF0Q28193560-65607D3D-6EC5-4CA3-AAAD-1FEE8BFF4DDBQ28193560-F083BA9A-1B0F-4F65-8191-EC2D4665273BQ28246832-83779627-A1EF-4A99-87B7-B5B2B57FF18CQ28565336-12FB3C57-F11C-4C17-885D-813FE1C081C8Q28572142-E28A0FE6-444F-4B1A-9453-05597A16F000Q28572557-4A47C420-056B-4B3C-8E42-6A27F5D5496AQ28574027-7056AD76-8079-4806-B0BD-9ED51D762AD0Q30366570-90F255F6-315F-44F1-B936-2D1138FB61CDQ30470322-0276C05E-97A5-4E54-8154-A4FB6864FB20Q30498118-E4DEE06E-8A0A-4A78-8F53-8F6E18022F1CQ30815476-B2117528-F28B-4DB5-A33D-7A5F45F2D23FQ33217600-64416AAE-8C00-4807-89C7-30EB50D7F652Q33504417-0C47E11C-7E47-4277-A44F-433126320303Q33594512-3D1C0435-D374-4B7F-B4EF-BA3078DD4637Q33594642-39BDCAB8-8CB6-4B7B-9B2B-1A04C3DC8E57Q33642062-A7A0ACF8-84BD-4279-A620-CB3DFAAA9EE4Q33675787-F454415D-7E39-4FC1-B145-0251C63A57D2Q33684178-B2B60941-C577-412A-9849-DAF381A02FE8Q33798597-54943096-09BE-4C7C-90F4-0E2DEE60FBE6Q33967433-5CEBC411-8DBE-45B0-B95A-51CE8CCF5B02Q33992920-FEF776A1-E575-4F34-8A69-6F580E200BC8Q33993544-44E2C406-779D-4113-86D3-ADE31283A48EQ34027474-14FA1317-2CBE-49F3-A0FB-E9A09BED9029Q34038951-E7159817-CC4A-41BF-92CA-96B0A6168F8AQ34057891-98349360-AB38-49F7-B8B4-BFCB60AA1234Q34074371-EBA63346-1614-4B57-BB75-A966E2040DF8Q34596103-8920F30D-6A87-431B-B3BC-5718840C4413Q34625689-E4E810CA-D8B2-4770-80D1-8412BD448AA5Q34644107-4A52D091-FA77-442C-AB85-52C3E8D6223EQ34684607-0F4C1426-1726-4FFE-A175-C385C424BBBAQ34707553-2E129B84-428F-406C-96B4-3A0579D8DE54Q34739730-225911A4-2106-4B34-9DDA-83F66D3913EDQ34814929-68E2DE6A-A9E7-4664-A96F-C9D71BD41854Q34814929-82E83E61-CF94-477B-8596-A9C5F0DC831CQ34905796-942C6F99-1312-4E29-8BE5-D88C7275C200
P50
description
physician and infectious disease researcher
@en
wetenschapper
@nl
name
David M Aronoff
@ast
David M Aronoff
@nl
David Michael Aronoff
@en
type
label
David M Aronoff
@ast
David M Aronoff
@nl
David Michael Aronoff
@en
altLabel
DM Aronoff
@en
David Aronoff
@en
prefLabel
David M Aronoff
@ast
David M Aronoff
@nl
David Michael Aronoff
@en
P101
P106
P1416
P101
P1416
P21
P31
P496
0000-0003-4587-6121